CLINICAL_TRIALS
trial_result
· 2017-02-14
Clinical Trial Update: PCI-24781 in Combination With Doxorubicin to Treat Sarcoma [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial evaluating PCI-24781 in combination with doxorubicin for sarcoma has completed, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Sarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-02-14